Clinical Trial Update: DNA Chip Based Prognosis of Lung Cancer

View source ↗

Summary

Completed clinical trial evaluating a DNA chip-based prognosis method for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Medical Prognosis Institute A/S | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED